Login with your work email address to view charts. No credit card required.
| Art Unit: | 1657 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts |
| Classes: |
435 — Chemistry: molecular biology and microbiology 424 — Drug, bio-affecting and body treating compositions 264 — Plastic and nonmetallic article shaping or treating: processes 536 — Organic compounds -- part of the class 532-570 series 506 — Combinatorial chemistry technology: method, library, apparatus 504 — Plant protecting and regulating compositions 600 — Surgery |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr(Biomedical Engrg) |
| Service: | 5 years |
| Grade: | GS-09 |
| 3-Year Grant rate: | 14% over 74 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 95th
|
With Examiner Mishra, you have a 14% chance of getting an issued patent by 3 years after the first office action. Examiner Mishra is an extremely hard examiner and in the 95th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Mishra, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Mishra's grant rate is lower than that of Art Unit 1657 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Mishra | 2.5 |
| Art Unit 1657 | 1.8 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.